Tuberculosis deaths rose for the first time in more than a decade due to the COVID-19 pandemic
On Oct. 14, 2021, the World Health Organization announced that the COVID-19 pandemic had reversed years of global…
Moderna announced FDA Advisory Committee unanimously voted in support of EUA for booster dose of COVID-19 vaccine
On Oct. 14, 2021, Moderna confirmed that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological…
NIH RADx initiative expanded COVID-19 testing innovation for additional types of rapid tests
On Oct. 14, 2021, The NIH Rapid Acceleration of Diagnostics (RADx) initiative announced that it has issued contract…
Democratic Republic of the Congo started Ebola vaccination
On Oct. 13, 2021, the Ministry of Health of the Democratic Republic of the Congo announced that vaccination…
Biotechnology | COVID-19 | HIV | Life Science History | Non-Profit Research | Polio | Therapeutics | Vaccine | WHO
WHO bestowed posthumous award on the late Henrietta Lacks
On Oct. 13, 2021, the World Health Organization (WHO) honoured the late Henrietta Lacks with a WHO Director-General’s…
Lucira’s Health COVID-19 test approved for sale in Singapore
On Oct. 12, 2021, Lucira Health announced that it had received PSAR approval for its Lucra CHECK IT…
Moderna announced COVAX exercised option to purchase 176.5 million additional doses of Moderna’s COVID-19 vaccine
On Oct. 12, 2021, Moderna announced that Gavi, the Vaccine Alliance had exercised its option to purchase an…
INOVIO announced preprint publication of homologous boosting data for its COVID-19 DNA vaccine candidate INO-4800
On Oct. 12, 2021, Inovio Pharmaceuticals announced online preprint publication in MedRxiv of Phase 1 clinical data on…
COVID-19 | Disease | HIV | Measles | Medicine | Pharmaceutical | Therapeutics | Vaccine
Resilience collaborated with Children’s Hospital of Philadelphia to develop next-gen biomanufacturing technologies
On Oct. 12, 2021, National Resilience announced a strategic collaboration with Children’s Hospital of Philadelphia (CHOP) to implement…
CureVac shifted focus of COVID-19 vaccine development to second-generation mRNA technology
On Oct. 12, 2021, CureVac announced the strategic decision to focus its COVID-19 vaccine development towards the development…
INOVIO expanded INNOVATE phase 3 for INO-4800 to include Colombia
On Oct. 11, 2021, Inovio Pharmaceuticals announced that it had received authorization from Colombia’s INVIMA, to conduct the…
Merck and Ridgeback announced Submission of EUA to the FDA for Molnupiravir, an Investigational Oral antiviral medicine, for treatment of COVID-19
On Oct. 11, 2021, Merck and Ridgeback Biotherapeutics announced that Merck had submitted an Emergency Use Authorization (EUA)…
Washington University School of Medicine reported antiviral compound blocked SARS-CoV-2 from entering cells
On Oct. 11, 2021, scientists at Washington University School of Medicine in St. Louis announced they had developed…
Ebola case reported in the Democratic Republic of the Congo
On Oct. 8, 2021, the Ministry of Health of the Democratic Republic of the Congo announced that a…
WHO, UN set out steps to meet world COVID vaccination targets
On Oct. 7, 2021, the World Health Organization launched the Strategy to Achieve Global Covid-19 Vaccination by mid-2022…
Moderna announced state-of-the-art mRNA facility in Africa to manufacture up to 500 million doses per year
On Oct. 7, 2021, Moderna announced it was building a state-of-the-art mRNA facility in Africa with the goal…
Duke University-led study showed Vaxart’s oral COVID-19 vaccine candidate reduced transmission of SARS-CoV-2 infection
On Oct. 7, 2021, Vaxart announced that a Duke University-led study published in bioRxiv showed that Vaxart’s (investigational…
PerkinElmer received FDA Emergency Use Authorization for respiratory SARS-CoV-2 panel
On Oct. 7, 2021, PerkinElmer announced that the U.S. Food and Drug Administration (FDA) had issued Emergency Use…
U.S. CDC reported more than 140,000 U.S. children lost a primary or secondary caregiver due to COVID-19 pandemic
On Oct. 7, 2021, the Centers for Disease Control and Prevention (CDC) reported One U.S. child loses a…
Diagnostics | NIH | Vaccine
BD unveiled Nebraska-based manufacturing capacity to support U.S. vaccination agility and preparedness
On Oct. 7, 2021, BD (Becton, Dickinson) announced it had strengthened the U.S. government’s access to safety injection…
Washington University School of Medicine in St. Louis led pediatric COVID-19 vaccine trial launched
On Oct. 6, 2021, Washington University School of Medicine announced the start of a pediatric COVID-19 vaccine clinical…
AIM ImmunoTech published phase 1 clinical study data supporting the safety of Ampligen as intranasal therapy
On Oct. 6, 2021, AIM ImmunoTech released detailed safety data from a Phase 1 clinical study which supported…
WHO recommended groundbreaking malaria vaccine for children at risk
On Oct. 6, 2021, the World Health Organization recommended widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among…
NIH researchers linked depression during pregnancy to placental gene modifications
On Oct. 6, 2021, a study by researchers at the National Institutes of Health (NIH) found that episodes…
NIH BRAIN Initiative unveiled detailed Atlas of the Mammalian Primary Motor Cortex
On Oct. 6, 2021, the The NIH Brain Research through Advancing Innovative Neurotechnologiesﾮ (BRAIN?) Initiative Cell Census Network…
Vaxartﾠbegan recruiting in global phase II COVID-19 oral tablet vaccine clinical trial
On Oct. 6, 2021, Vaxart announced that it had begun recruiting subjects for its Phase II COVID-19 oral…
USDA confirmed COVID-19 infection in a Binturong and a Fishing Cat at an Illinois Zoo
On Oct. 6, 2021, the U.S. Department of Agriculture’s Agriculture Research Service (ARS) announced confirmation of SARS-CoV-2 (the…
Lumen Bioscience awarded Federal funding to advance Covid-19 antibody cocktail through phase 2 clinical evaluation
On Oct. 6, 2021, Lumen Bioscience announced new development funding from the US Army for its Covid-19 monoclonal…
Johnson & Johnson submitted EUA amendment to FDA to support booster of single-shot COVID-19 vaccine
On Oct. 5, 2021, Johnson & Johnson announced it had submitted data to the U.S. Food and Drug…
Moderna announced EMA authorized third dose of COVID-19 vaccine for immunocompromised individuals aged 12 years and older
On Oct. 5, 2021, Moderna announced that the European Medicines Agency (EMA) had authorized a third dose of…